10-22208893-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001394757.1(EBLN1):c.1091G>A(p.Gly364Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000299 in 1,521,550 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001394757.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 9AN: 119104Hom.: 0 AF XY: 0.000107 AC XY: 7AN XY: 65334
GnomAD4 exome AF: 0.000321 AC: 440AN: 1369422Hom.: 1 Cov.: 29 AF XY: 0.000310 AC XY: 209AN XY: 674250
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.1091G>A (p.G364E) alteration is located in exon 1 (coding exon 1) of the EBLN1 gene. This alteration results from a G to A substitution at nucleotide position 1091, causing the glycine (G) at amino acid position 364 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at